- Consistent effects seen across key MRI measures of disease activity; Effects were sustained beyond two-year pivotal MS studies. <br><br>
- Approximately 80 percent of patients treated with Lemtrada did not receive a third course of treatment in the first year of the extension........ Read more - http://www.ms-uk.org/lemtrada
Lemtrada slows brain atrophy and reduces new MS lesions
Lemtrada slows brain atrophy and reduces new MS lesions
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1357 Views
-
Last post by NHE
-
- 0 Replies
- 1935 Views
-
Last post by frodo
-
- 0 Replies
- 655 Views
-
Last post by frodo
-
- 0 Replies
- 1702 Views
-
Last post by NHE
-
- 0 Replies
- 11114 Views
-
Last post by accordingnature495
-
- 0 Replies
- 1192 Views
-
Last post by NHE
-
- 4 Replies
- 1490 Views
-
Last post by NHE
-
- 0 Replies
- 1483 Views
-
Last post by NHE
-
- 3 Replies
- 4861 Views
-
Last post by NHE